Across primary care practices, guideline adherence remains suboptimal for chlamydia and gonorrhea, according to a study ...
For all treated chlamydia infections, 14.0% of patients received doxycycline—the CDC's recommended treatment—alone or with ...
Higher treatment rates were seen for females, individuals aged 10 to 29 years, suburban dwellers, and patients with chlamydia-gonorrhea coinfection. HealthDay News — Across primary care ...
This study aimed to quantify the overall treatment rate for chlamydia and gonorrhea and identify factors associated with treatment delays and disparities.
10 天
News-Medical.Net on MSNDisparities identified in treatment of chlamydia and gonorrhea in primary carePrompt treatment of chlamydia and gonorrhea following a confirmed diagnosis is essential to prevent complications and reduce ...
Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.
Jean-François Toussaint, Sanofi's global head of vaccines R&D, speaking at a conference at the company's site in Lyon last ...
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer ...
Key points A 40-year-old man was referred to our internal medicine clinic for assessment of a 3-month history of unintentional weight loss and daily night sweats with subjective fevers. He had been ...
Universal opt-out programs raise sexually transmitted infection screening rates in adolescents, though confidentiality issues may affect commercially insured patients.
As part of the Fast Track designation, Sanofi is set to launch a Phase I/II trial to evaluate the immunogenicity and safety of its novel mRNA vaccine in preventing chlamydia.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果